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Synaptic plasticity alters the strength of information flow between presynaptic and
postsynaptic neurons and thus modifies the likelihood that action potentials in a
presynaptic neuron will lead to an action potential in a postsynaptic neuron. As such,
synaptic plasticity and pathological changes in synaptic plasticity impact the synaptic
computation which controls the information flow through the neural microcircuits
responsible for the complex information processing necessary to drive adaptive behaviors.
As current theories of neuropsychiatric disease suggest that distinct dysfunctions in
neural circuit performance may critically underlie the unique symptoms of these diseases,
pathological alterations in synaptic plasticity mechanisms may be fundamental to the
disease process. Here we consider mechanisms of both short-term and long-term
plasticity of synaptic transmission and their possible roles in information processing by
neural microcircuits in both health and disease. As paradigms of neuropsychiatric diseases
with strongly implicated risk genes, we discuss the findings in schizophrenia and autism
and consider the alterations in synaptic plasticity and network function observed in both
human studies and genetic mouse models of these diseases. Together these studies have
begun to point toward a likely dominant role of short-term synaptic plasticity alterations
in schizophrenia while dysfunction in autism spectrum disorders (ASDs) may be due to a
combination of both short-term and long-term synaptic plasticity alterations.
Keywords: neuropsychiatric diseases, short-term synaptic plasticity, neural circuits, 22q11.2 microdeletion, DISC1,
schizophrenia, autism spectrum disorder, risk genes
INTRODUCTION—NEUROPSYCHIATRIC DISEASE
MANIFESTATIONS AND HYPOTHESES OF NEURAL CIRCUIT
DYSFUNCTION
The recent advances over the past several decades in molecu-
lar biology, human genomics, and bioinformatics has helped to
enable the identification of numerous candidate genes and dis-
tinct genetic mutations in a variety of human neuropsychiatric
illnesses that may be the responsible agents for causing their
symptomology. Based on the genetic mutations identified by
human genomic analyses, many of these mutations have been
introduced into the mouse genome to create genetic mouse mod-
els of these human diseases in the hope that the invasive and
precisely refined experimentation permitted in mice will help
to reveal the details of the molecular and neuronal dysfunction
underlying these diseases. Despite the availability of these pow-
erful experimental tools, the daunting molecular, anatomic, and
functional complexity of the central nervous system demands that
targeted and well-considered hypotheses be generated within this
overwhelming complex system in order to direct experimental
investigations to the systems and processes where dysfunction is
most likely to be found in each unique disease.
When considering the underlying mechanistic causes of the
dysfunction and symptomology of neuropsychiatric diseases, a
thoughtful consideration of the most prominent features and
most characteristic symptoms of each disease is a useful start-
ing point for hypothesis generation. It has been proposed that the
core commonality of dysfunction amongst neuropsychiatric dis-
eases is a deficit in the information processing performed both by
and between the various neural microcircuits located through-
out the brain (Yizhar et al., 2011; Uhlhaas and Singer, 2012).
Although multiple parameters work together to determine the
computations performed by neural circuits, the synaptic plastic-
ity that dynamically regulates synaptic function and hence the
information flow between neurons at each of the millions of
synapses throughout a neural microcircuit is thought to play a
fundamental role in this microcircuit computation (Abbott and
Regehr, 2004).While short-term synaptic plasticity leads to short-
term changes in synaptic function (lasting from milliseconds to
minutes) that regulate the moment-to-moment information flow
through a neural circuit, long-term synaptic plasticity leads to
persistent changes in synaptic function (lasting from hours to the
lifetime of the synapse) that fundamentally and adaptively alters
microcircuit function in response to activity indicating changing
computational demands (Zucker and Regehr, 2002; Collingridge
et al., 2010; Granger and Nicoll, 2013). Due to this critical
role in controlling microcircuit computation, here we consider
dysfunction in both long-term and short-term synaptic plastic-
ity mechanisms as promising candidates underlying the neural
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microcircuit dysfunction that is likely responsible for neuropsy-
chiatric disease symptomology (Table 1). While dysfunction in
distinct neuropsychiatric diseases may result from alterations in
either or both short-term and long-term synaptic plasticity, as a
paradigm, studies of schizophrenia—where short-term synaptic
plasticity alterations dominate—serve as an illustrative example
of how targeted hypotheses of synaptic plasticity dysfunction can
be formulated by beginning with the temporal nature of disease
manifestations as a strategic starting point.
Schizophrenia is a relatively common and severely debilitating
psychiatric illness that is characterized by a somewhat variable
yet core set of clinical symptomology. Although the most strik-
ing features of schizophrenics are their disorganized thinking and
speech, delusions, and hallucinations (so-called positive symp-
toms of psychosis), the disease is also characterized by both
“negative” symptoms (e.g., social withdrawal, blunted emotional
range, lack of motivation, anhedonia) as well as severe cogni-
tive deficits that may in fact contribute more substantially to
functional disability and quality of life than the more prominent
positive symptoms (Ranganath et al., 2000; Carter et al., 2008;
American Psychiatric Association, 2013).
Current drug therapies, while substantially efficacious in treat-
ing positive symptoms, show little benefit in correcting the
more disabling cognitive and negative symptoms and disease-
preventative measures are currently non-existent (Buchanan
et al., 2007; Brown and McGrath, 2011). Schizophrenia research
Table 1 | Synaptic plasticity mechanisms and information flow.
Synaptic plasticity Cellular mechanism involved Duration of functional
change
Affect on information flow
Short-term NT-release pathways (Pr)
NT-receptors
Transient
Short-lived
Inherent synaptic dynamics that normally determine
moment to moment synaptic/network information flow
Presynaptic depression Reduced presynaptic NT release
High initial Pr, NT release
↓Pr – ↑NT-vesicle depletion (↓RRP)
ms – minutes Time-dependent filtering:
Postsynaptic neuron receives LP filtered information from
presynaptic neuron
Onset/change/transient detection
Presynaptic facilitation Increased presynaptic NT release
Low initial Pr, NT release
↑Pr – ↑Residual presynaptic Ca2+
ms – minutes Time-dependent filtering:
Postsynaptic neuron receives HP filtered information from
presynaptic neuron
Burst/rate detection
Postsynaptic depression Reduced postsynaptic NT responses
NT-receptor saturation/desensitization
ms – minutes Similar to presynaptic depression
Augmentation
PTP
Increased NT release, ↑Pr
Unresolved: ↑RRP, prolonged residual
Ca2+, ↑Ca2+ flux, Ca2+ sensitivity of
NT release
10 s of seconds
10 s of seconds – mins
Allows maintenance of information flow during periods of
high activity that would otherwise be reduced by ST
depression
Long-term NT-receptors NT-release (Pr)
Structural changes
Persistent, long-lived
Hours – lifetime
Transiently induced, long-lived changes synaptic function
that fundamentally and persistently alter synaptic/network
computation
LTD-presynaptic Reduced presynaptic NT release
Decreased initial Pr
Persistent, hours+ Changes ST synaptic dynamics
Shifts ST plasticity toward more facilitating, HP filtering
LTD-postsynaptic Reduced postsynaptic NT response
↓NT-receptor number/function
Persistent, hours+ Decreases postsynaptic gain
Time-independent, decreases information flow at all
frequencies
LTP-presynaptic Increased presynaptic NT release
(increased initial Pr)
Persistent, hours+ Changes ST synaptic dynamics
Shifts ST plasticity toward more depressing, LP filtering
LTP-postsynaptic Increased postsynaptic NT response
↑NT-receptor number/function
Persistent, hours+ Increases postsynaptic gain
Time-independent, increases in information flow at all
frequencies
Summary of short-term and long-term synaptic plasticity mechanisms and their impact upon synaptic and network information flow. Abbreviations: NT, neurotrans-
mitter; Pr, the probability of neurotransmitter release; RRP, readily releasable pool of NT-vesicles; LP, low-pass filtering, the preferential transmission of information to
the postsynaptic neuron at lower presynaptic activity rates; HP, high-pass filtering, the preferential transmission of information to the postsynaptic neuron at higher
presynaptic activity rates; ST, short-term; LT, long-term; PTP, post-tetanic potentiation; LTP, long-term potentiation; LTD, long-term depression.
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targeted at understanding the precise molecular and neuronal
mechanisms underlying disease dysfunction represents the most
promising path toward more efficacious therapy and cure. To
achieve these ends, genetic mouse models based upon robust
candidate schizophrenia susceptibility genes identified by human
genomic studies have recently been employed. These genetic
mouse models are currently the best available analytical platform
as they permit the invasive, high-resolution studies—impossible
to conduct in human subjects—necessary to identify and eluci-
date the precise disease mechanisms present in neuropsychiatric
diseases at the neuronal and molecular level (Arguello et al.,
2010). At present, combining thoughtful consideration and anal-
ysis of human symptomology and the findings from mouse
models based upon bone fide schizophrenia genetic risk vari-
ants has begun to suggest that, while long-term synaptic plasticity
mechanisms may be relatively intact, there is an important and
dominant role of short-term synaptic plasticity dysfunction in
schizophrenia pathogenesis (Arguello and Gogos, 2012).
Although the clinical presentation and evolution of the
schizophrenia can be highly variable, cognitive impairment fre-
quently pre-dates diagnosis which often initially presents with
the psychotic positive symptoms while negative symptoms usu-
ally becomemore prominent only at later times (O’Carroll, 2000).
This evolution of symptomology strongly suggests that cogni-
tive and psychotic symptomology may represent the primary
disease process and be fundamental to understanding disease
mechanisms. Significantly, both the specific cognitive deficits
and psychotic features characteristic of schizophrenia suggest a
fundamental problem with the moment-to-moment informa-
tion processing performed by neural circuits within the brain
(Compte et al., 2000; Mongillo et al., 2008). The cognitive deficits
in schizophrenia are both pervasive and profound and range
from impaired sensory processing to deficits in the cognitive
control mechanisms necessary to manage and organize informa-
tion (Barch, 2009; Dias et al., 2011; Lesh et al., 2011). Although
schizophrenics show deficits in both working memory (a short-
term memory process) and episodic memory (involving both
short- and long-term processes), performance testing in human
subjects suggests that both of these deficits likely involve an
underlying deficit in short-term information management as
episodic memory deficits can be overcome by employing cer-
tain encoding strategies indicating that long-term recall processes
are largely intact (Holthausen et al., 2003; Ragland et al., 2005;
Bonner-Jackson et al., 2008; Van Snellenberg, 2009).
The psychotic features of schizophrenia likewise point toward
a deficit in the short-term processing of information. The nature
of disorganized speech, hallucinations, and delusions all point
to a moment-to-moment deficit in the instantaneous processing
of on-going streams of information rather than a deficit involv-
ing long-term processes. Moreover, the drug-responsiveness of
psychosis—as well as the ability of certain drugs and medica-
tions to induce psychosis in healthy individuals—further suggests
a likely subtle defect in the dynamics of short-term information
processing rather than a significant derangement or degeneration
of microcircuit connectivity or architecture (Arguello and Gogos,
2012). Thus, taken together, both the psychosis and the nature of
the cognitive deficits in schizophrenia strongly suggest pathologic
alterations heavily weighted toward dysfunction in short-term
information processing dynamics by neural microcircuitry. Given
that the short-term, ongoing information processing performed
by neural circuits is believed to be largely dictated by the short-
term synaptic plasticity that controls the instantaneous dynamics
of synaptic information flow strongly suggests that the neural cir-
cuit dysfunction in schizophreniamay to a large extent result from
underlying alterations in short-term synaptic plasticity (Abbott
and Regehr, 2004; Mongillo et al., 2008; Deng and Klyachko,
2011). Consistent with this hypothesis, studies in genetic mouse
models of schizophrenia have found that the cognitive and synap-
tic plasticity alterations observed in these mice are dominated by
deficits in working memory and short-term synaptic plasticity
rather than in episodic memory and long-term synaptic plasticity
(Koike et al., 2006; Kvajo et al., 2008; Stark et al., 2008; Sigurdsson
et al., 2010; Drew et al., 2011b; Fénelon et al., 2011, 2013; Arguello
and Gogos, 2012).
While at a biological top level it would seem necessary that
disease dysfunction must follow gene dysfunction, the lack of
full penetrance of schizophrenia within pedigrees—most notably
the only 50% concordance betweenmonozygotic twins—suggests
that while gene dysfunction clearly plays a prominent role,
other factors are also significantly contributing to disease genesis
(Karayiorgou and Gogos, 1997). There is broad supporting data
that environmental factors act both in concert with genetic back-
ground as well as epigenetically to enhance risk for schizophrenia
(Prasad et al., 2010). Significant environmental risk factors pre-
disposing to schizophrenia may include—but are not limited to—
a variety of chronic, early-life social, emotional, and metabolic
stressors, perinatal viral illness and hypoxic insults, and chronic,
early-life use of some drugs of abuse, most significantly cannabis
(Vilain et al., 2013; Schmitt et al., 2014). Despite the importance
of identifying these risk factors, both risk genes and environmen-
tal factors still remain at a frustrating distance from a detailed,
mechanistic understanding by which they lead to the deranged
information processing at the level of the neural circuit dysfunc-
tion underlying disease (Lisman et al., 2008; Hu et al., 2010;
Sigurdsson et al., 2010; Steullet et al., 2010; Arguello and Gogos,
2012; Filipovic´ et al., 2013; Spellman and Gordon, 2014).
Although the molecular and neuronal dysfunction that leads
to psychosis and schizophrenia remains poorly understood, the-
ories of dysregulation of neurotransmitter systems including
hyper-function of dopaminergic systems and hypo-function of
glutamatergic systems (principally NMDA receptors) have been
proposed as candidates underlying altered synaptic plasticity
(Blum andMann, 2002; Baldessarini and Tarazi, 2006). These the-
ories, which were largely developed prior to the genomic era and
were originally based upon clinical observations of responses to
various drugs and medications that either precipitated or ame-
liorated psychosis, have been heavily investigated and at times
supported by findings in a variety of models of schizophre-
nia (Mohn et al., 1999; Lahti et al., 2001; Dalmau et al., 2007;
Manahan-Vaughan et al., 2008; Wiedholz et al., 2008; Ecker et al.,
2009; Belforte et al., 2010; Carlén et al., 2012; Inta et al., 2014). But
whether manipulations of these neurotransmitter systems simply
phenotypically mimic the symptoms of schizophrenia or whether
alterations in these NT systems are truly fundamental to the
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human disease process still remains unknown. Intriguingly, how-
ever, the genetic risk variants identified in most genomic studies
have only rarely been found to be among those genes compris-
ing the principal components of these neurotransmitter systems
which suggests that if alterations of these NT systems are fun-
damentally involved in schizophrenia they must be so indirectly
through the downstream actions of risk genes (Glatt et al., 2003).
Thus, while it would likely be unwise not to explore the func-
tion of these NT systems in mouse models based upon human
genetic risk variants, it may also be equally unwise to view these
models without more unbiased eyes. We would suggest a broader
and more measured investigative approach centered upon mouse
models based upon bone fide genetic risk variants as a means
to approach neural circuit dysfunction in disease though inves-
tigative analysis of the substrates most fundamentally involved
in determining neural circuit function, principally synaptic plas-
ticity and neural circuit architecture. By taking advantage of the
unbiased nature of identifying genetic risk variants as a gateway to
unravel disease-relevant neural circuit dysfunction, this approach
may likely be the most fruitful and efficacious means to reveal the
functional and molecular details of disease mechanisms required
to create the most effective, targeted therapeutics.
This example of the hypothesis development and experimen-
tal approach for schizophrenia thus serves as a paradigm for
the effective approach to the study of other neuropsychiatric
diseases by showing how high-risk susceptibility genes found
through human genomic studies can be used to develop genetic
mouse models that not only recapitulate the behavioral deficits
found in human disease but that further allow detailed analysis
of the neuronal, synaptic, and neural circuit dysfunction under-
lying these behavioral alterations. As neural circuit dysfunction
is a common underlying feature in neuropsychiatric disease, a
research strategy focusing upon assessing the function of distinct
neural circuits implicated in disease symptomology and the neu-
ronal and synaptic mechanisms that underlie their function will
likely provide the optimally productive approach for revealing
the fundamental molecular mechanisms underlying neuropsychi-
atric disease (Lisman et al., 2008; Akil et al., 2010; Arguello and
Gogos, 2012). While the unique symptomology of schizophrenia
strongly suggests that neural circuit dysfunction may be predom-
inantly due to alterations in short-term synaptic plasticity, the
varied symptomology within the spectrum neuropsychiatric dis-
eases can likewise be used to guide targeted experiments assessing
the unique contributions of short-term and long-term synaptic
plasticity mechanisms underlying neural circuit dysfunction in
distinct neuropsychiatric diseases.
POTENTIAL CAUSES OF NEURAL CIRCUIT DYSFUNCTION IN
NEUROPSYCHIATRIC DISEASE
The commonality of dysfunction among the psychiatric diseases
is a failure of the brain to process information appropriately
in order to produce a normal and appropriate response to the
demands of a given task or situation. While the specific details
of how the brain accomplishes the processing of information
remain understood at only the most rudimentary level, it seems
apparent that the informational computation performed by neu-
ral circuits is critical to the interpretation of the world around
us that ultimately leads to adaptive and advantageous behavioral
responses (Uhlhaas and Singer, 2006, 2012; Yizhar et al., 2011).
Although this review focuses exclusively upon the role of synaptic
plasticity alterations in neuropsychiatric disease and their roles in
neural microcircuit dysfunction, it is useful to first acknowledge
and consider alternative paths that can also lead to the outcome of
network dysfunction in neuropsychiatric disease. Neural micro-
circuit function is principally determined by three factors: (1) the
network architecture that is defined by the synaptic connectiv-
ity between the neurons within a microcircuit, (2) the synaptic
plasticity which dynamically regulates the strengths of these indi-
vidual synapses and ultimately controls the information flow
between the neurons in the network, and (3) the postsynaptic
ensemble integration of these synaptic inputs that determines
whether synaptic information received from presynaptic neurons
successfully leads to an AP in the post-synaptic neuron. Thus, in
considering potential neuronal causes of neural circuit dysfunc-
tion, it is possible to envision a comprehensive yet manageable set
of pathologic scenarios that could lead to impaired neural circuit
function in neuropsychiatric disease.
In perhaps the simplest scenario, the architecture and con-
nectivity of the neural circuit could be normal and the intrinsic
function of the neurons and synapses within the circuit could
be normal while some outside factor could be causing neural
circuit dysfunction. That both electrolyte imbalances as well as
exogenous drugs and medications can alter neuronal function
and acutely cause psychiatric symptomology suggests that similar
mechanisms could play causal roles in neural circuit dysfunc-
tion in chronic neuropsychiatric disease (Webb and Gehi, 1981;
Morton, 1999; Turjanski and Lloyd, 2005). Both the dopamin-
ergic agonists and NMDA receptor antagonists that precipitate
acute psychotic states that mimic the psychosis of schizophrenia
appear to operate by this mechanism in the context of presumably
otherwise normal basal neural circuit function (Lahti et al., 2001;
Manahan-Vaughan et al., 2008; Ecker et al., 2009).
In another scenario in which neural circuit architecture is nor-
mal, alterations in either neuronal or synaptic function could lead
to pathological alterations in neural circuit performance. Changes
in either the excitability of the neurons within the circuit or the
regulation by synaptic plasticity of the strengths of the synapses
that define the functional connectivity of the circuit will alter the
information flow through the circuit and thus lead to disrup-
tions of neural circuit computation (Matveev and Wang, 2000;
Zheng et al., 2004; Deng and Klyachko, 2011; Rotman et al., 2011;
Yizhar et al., 2011; Ransdell et al., 2012). Current paradigms of
schizophrenia and autism implicating the prominent alterations
in synaptic plasticity observed in mouse models based on iden-
tified human genetic risk variants suggest that such functional
changes alone could be largely responsible for neural circuit dys-
function (Markram and Markram, 2010; Arguello and Gogos,
2012).
In a complementary scenario in which both neuronal and
synaptic function are normal, alterations in neural circuit archi-
tecture alone could similarly lead to alterations in the information
processing performed by neural circuits. The neuron to neu-
ron connectivity created by the synapses between neurons is a
critical determinant in neural circuit function and alterations in
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this circuit architecture would have a significant impact upon
information processing. Such alterations in connectivity in neural
circuits likely play a central role in the neural circuit dysfunc-
tion in neurodegenerative diseases in which neuronal death and
the inability to grow and maintain new synaptic connections
would be expected to significantly alter neural circuit architec-
ture (Hensch, 2005; Le Be and Markram, 2006; Pratt et al., 2008;
Ricoy et al., 2011). Both the prominent progressive synaptic and
neuronal degeneration observed in Alzheimer disease and the
emerging role of deficient adult neurogenesis in major depres-
sion suggest that alterations in neural circuit architecture and the
dynamic maintenance of that architecture may alone play sub-
stantial roles in neural circuit dysfunction (Selkoe et al., 2012;
Miller and Hen, 2015).
In a final scenario, it is possible to have information process-
ing abnormalities in the context of both normal neural circuit
architecture and normal neuronal and synaptic function if the
long-range connectivity between distinct neural circuits in differ-
ent brain regions is altered. As complex behaviors and decisions
frequently require the transmission of information processed in
a neural circuit in one brain region to another circuit located
in a distant brain region, the appropriate functional connectivity
between these distinct neural circuits is critical to effective global
information processing within the brain (Achard et al., 2006;
Wang, 2010; Modha and Singh, 2010). Suggesting an important
causal role in neuropsychiatric pathophysiology, prominent alter-
ations in long-range connectivity between brain regions have long
been implicated in major depression and have also more recently
been implicated in schizophrenia, autism, and OCD (Lawrie
et al., 2002; Nestler et al., 2002; Belmonte et al., 2004; Meyer-
Lindenberg et al., 2005; Geschwind and Levitt, 2007; Murias
et al., 2007; Welch et al., 2007; Krishnan and Nestler, 2010; Lynall
et al., 2010; Markram andMarkram, 2010; Sigurdsson et al., 2010;
Ahmari et al., 2013; Brennan et al., 2013; Uhlhaas, 2013).
Furthermore, apart from the distinct scenarios presented
above, it is possible—if not likely—that the information process-
ing deficits present in neuropsychiatric illnesses could be caused
by neural circuit dysfunction that is due to a combined dysfunc-
tion of the mechanisms presented in these individual scenarios.
Despite this diversity of mechanisms potentially responsible for
neural circuit dysfunction, here in this review we focus solely
upon the possible role of alterations in synaptic plasticity as con-
tributing to the dysfunction of information processing by neural
circuits in neuropsychiatric diseases. Alterations in synaptic plas-
ticity mechanisms represent particularly attractive candidates for
information processing dysfunction in neuropsychiatric disease
as their impact upon the dynamics of information flow through
neural circuits appears particularly critical to the computation
performed by these circuits (Abbott and Regehr, 2004; Mongillo
et al., 2008; Deng and Klyachko, 2011). Although a detailed
understanding of the information processing performed by neu-
ral circuits currently remains out of reach, convergent results from
experimental and theoretical studies strongly suggest that synap-
tic plasticity—and in particular short-term synaptic plasticity—is
fundamental in governing these computations (Markram and
Tsodyks, 1996; Tsodyks and Markram, 1997; Milner et al., 1998;
Dobrunz and Stevens, 1999; Martin et al., 2000; Abbott and
Regehr, 2004; Whitlock et al., 2006; Mongillo et al., 2008; Deng
and Klyachko, 2011).
In addition to synaptic plasticity mechanisms, however, there
are many other forms of plasticity within neural systems that can
also act upon neural circuits to modify their function. The growth
of new synaptic connections, the birth of new neurons via neuro-
genesis that then become incorporated into existing circuitry, the
modulatory impact of glial cells acting either alone or in concert
with neurons, and the actions of neurotrophic factors released
by either neurons or glia can all lead to significant changes in
the function and architecture of neural circuits and have all been
implicated in contributing to dysfunction in neuropsychiatric dis-
eases (Gottschalk et al., 1998; Gu, 2002; Lamprecht and LeDoux,
2004; Ghashghaei et al., 2006; Le Be and Markram, 2006; Reif
et al., 2006, 2007; Todd et al., 2006;Mao et al., 2009). As a compre-
hensive consideration of these diverse mechanisms is beyond the
scope of this review, however, herein we limit our consideration
exclusively to neuronal aspects of synaptic plasticity mechanisms
that act acutely in a synaptic activity-dependent manner to mod-
ify the function of pre-existing synapses within neural circuits and
the potential role of alterations in these mechanisms in the circuit
dysfunction in neuropsychiatric disease.
SYNAPTIC PLASTICITY AS A VANTAGE POINT FOR
PSYCHIATRIC DISEASE
While there still remains a daunting knowledge gap between the
symptomology of neuro-psychiatric disease and the causes of this
symptomology at the synaptic, neuronal, and neural circuit level,
considering how distinct forms of neuronal dysfunction might
be reflected in disease symptomology can be cautiously applied
toward hypothesis generation that can lead to targeted exper-
iments in understanding the underlying dysfunction in these
diseases. Broadly, neuropsychiatric diseases with both profound
and persistent symptomology—such as the more severe neurode-
velopmental and neurodegenerative disorders—suggest a more
fundamental and pervasive underlying neuronal derangement
while those diseases withmore nuanced and episodic symptomol-
ogy might suggest nearly normal neuronal, synaptic, and neural
circuit function with dysregulation occurring at the level of the
fine-tuning and modulation of neuronal, synaptic, and neural
circuit function (Table 1).
In considering the cognitive deficits present in Alzheimer’s dis-
ease (AD), for example, while there is some waxing and waning of
symptomology, the memory deficits characteristic of AD demen-
tia are largely persistent, pervasive, and progressive. While these
memory deficits are possibly due in part to deficits of long-term
plasticity, the major pathology underlying the dementia is likely
to be predominantly the consequence of the neuronal death and
degeneration that would fundamentally alter the connectivity of
neural circuits involved in memory formation and storage (rather
than due to alterations in the cellular mechanisms involved in LTP
per se). The plausibility of this interpretation is supported by the
broadly reported findings indicating that neuronal degeneration
and death, pervasive alterations in neuronal and synaptic mor-
phology, and deficits in synaptic maintenance are fundamental
characteristics of AD pathology. Thus, while the memory deficits
of AD do indeed imply neuronal and neural circuit dysfunction,
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these dysfunctions are likely a consequence of significant alter-
ations in functional connectivity between neurons that affect
neural circuit architecture rather than modulatory changes in
neuronal function that serve to sculpt information processing in
a largely intact and functional neural circuit. Taken together, both
the symptomology and the profound degeneration and neuronal
derangements present in AD dementia suggest that the underly-
ing disease dysfunction in most cases is not likely primarily due to
subtle changes in neuronal function such as alterations in synaptic
plasticity mechanisms.
In contrast to the case of AD, the nature of the psychotic symp-
tomology of both schizophrenia and bipolar disorder suggests
the likelihood of a much more nuanced neuronal dysfunction
that leads to information processing dysfunction. The severity
of psychotic symptomology in these diseases tends to be much
more episodic in nature suggesting periods of relatively normal
neuronal and neural circuit function. This episodic nature cou-
pled with the frequent responsiveness of psychosis to medication
supports a much more subtle alteration in information process-
ing, possibly in the context of both nearly normal neuronal and
neural circuit function. Further supporting the “nearly normal”
hypothesis of psychosis are the many drugs that can acutely lead
to transient psychotic symptomology in healthy individuals that
is clinically indistinguishable from the psychosis in psychiatric
disease. As these drugs can induce psychosis in individuals with
presumably normal baseline neuronal and neural circuit func-
tion, it is likely that psychosis in psychiatric disease can manifest
in the context of relatively minor perturbations in neuronal func-
tion. The moment-to-moment information processing deficits
that appear to be characteristic of psychosis suggest the possibil-
ity that short-term synaptic plasticity mechanisms—that control
the computational rules within neural circuits—may represent
the primary locus of dysfunction underlying this symptomol-
ogy. In further support of likely short-term plasticity dysfunction
in schizophrenia are the significant deficits in working memory
in schizophrenia. While the exact neural substrates of working
memory remain to be fully elucidated, both experimental as well
as theoretical work suggest that working memory is supported
largely by the short-term synaptic plasticity mechanisms at play
within neural networks. Thus, both the psychotic features as well
as the working memory deficits characteristic of schizophrenia
strongly suggest that short-term synaptic plasticity mechanisms
represent a promising target to explore for dysfunction, a notion
supported by results from studies in mouse models based on
valid schizophrenia risk genes which have most prominently dis-
played pronounced alterations in short-term synaptic plasticity
(Arguello and Gogos, 2012).
With this framework in mind, we next examine the evidence
for dysfunction in neuronal network performance and synaptic
plasticity in neuropsychiatric diseases for which robust, corre-
sponding genetic mouse models of disease have been created.
Despite the recent explosive progress in the identification of an
abundance of risk genes for various neuropsychiatric diseases,
only a very small subset of these identified genetic variants have
been found to be highly penetrant with respect to their ability to
reliably lead to disease. As such, the creation of etiologically valid
mouse models of disease based upon high-risk, highly penetrant
genetic variants has only been possible to date in a small subset
of neuropsychiatric diseases. Based upon these considerations, we
limit our consideration here to two diseases with the strongest
genetic mouse models: schizophrenia and autism.
SCHIZOPHRENIA
Schizophrenia is a heterogeneous disorder with an approximate
prevalence of 1% in most populations that most frequently
presents in late adolescence to early adulthood and has a strong
genetic component based upon the increased incidence observed
in twin studies and within in familial pedigrees (McGuffin
et al., 1995; Karayiorgou and Gogos, 1997; Sullivan et al., 2003;
Lichtenstein et al., 2009a). Schizophrenia is characterized by
positive symptoms (disordered thought and speech, delusions,
and hallucinations—classic psychotic features), negative symp-
toms (blunted emotional range, anhedonia, social withdrawal,
decreased motivation), and cognitive deficits (deficits in execu-
tive function, attention, and both episodic and working memory)
that together define the illness (O’Carroll, 2000; Forbes et al.,
2009; American Psychiatric Association, 2013). While the causes
of most cases of schizophrenia remain unknown, a combination
of genetic and environmental factors appears to collaborate in its
pathogenesis. A wide array of schizophrenia candidate risk genes
and genetic mutations have been identified—from both rare,
syndromic and familial cases as well as through large genomic
association studies—and have implicated genes with diverse func-
tion including those that are either known to or have since been
shown to affect synaptic function (Frankle et al., 2003; Gogos and
Gerber, 2006; Lisman et al., 2008; Xu et al., 2008, 2011, 2012;
Stefansson et al., 2009; Drew et al., 2011a; Girard et al., 2011;
Ripke et al., 2011, 2013; Rodriguez-Murillo et al., 2012). While
a subset of genomic studies has suggested that genetic risk vari-
ants may be potentially biased toward postsynaptically expressed
genes, mouse models based upon the most relevant and highly
penetrant risk variants have most often shown alterations in
short-term synaptic plasticity, which strongly implicates a presy-
naptic site of dysfunction (Kirov et al., 2012; Fromer et al., 2014;
Hall et al., 2014; but see Frankle et al., 2003; Xu et al., 2012).
Abnormalities in the functional connectivity between micro-
circuits in different brain regions have been put forth as an
important pathophysiological mechanisms underlying dysfunc-
tion in schizophrenia and functional imaging and EEG studies
in schizophrenia as well as studies in mouse models support
this possibility (Ford et al., 2002; Lawrie et al., 2002; Meyer-
Lindenberg et al., 2005; Esslinger et al., 2009; Stephan et al.,
2009; Sigurdsson et al., 2010; Brennan et al., 2013; Uhlhaas,
2013). Assessment of network function in schizophrenia with
EEG has shown increased local microcircuit activity as evidenced
by enhanced gamma-band oscillations under resting, unstimu-
lated conditions (Kikuchi et al., 2011; Spencer, 2012). In contrast
to the increased local microcircuit activity at rest, during a vari-
ety of cognitively demanding tasks local microcircuit activity is
significantly reduced as indicated by a reduction in gamma oscil-
lations during these tasks compared to healthy controls (Spencer
et al., 2003; Ford et al., 2008; Hirano et al., 2008; Haenschel
et al., 2009; Minzenberg et al., 2010). Furthermore, some of
the observed network alterations have also been seen in both
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unaffected monozygotic twins and healthy first-degree relatives
of schizophrenics suggesting that local circuit dysfunction may
represent a significant intermediate functional endophenotype
(Hong et al., 2008; Hall et al., 2011). Finally, in vivo plasticity stud-
ies conducted on schizophrenic sample groups have shown either
reductions or complete absence of long-term plasticity evoked
by transcranial stimulation indicating the possibility of signifi-
cant impairments in long-term plasticity induction mechanisms
(Fitzgerald et al., 2004; Daskalakis et al., 2008; Frantseva et al.,
2008; Hasan et al., 2011, 2012a,b, 2013).
Despite the large number of schizophrenia risk genes and gene
mutations implicated through variousmethodologies, only a sub-
set of these targets appear to be able to confer by themselves
a substantially increased risk of schizophrenia. Furthermore,
amongst this subset the directionality and nature of the func-
tional change (e.g., reduced expression or function vs. enhanced
expression or function) caused by the genetic mutations that is
required to create an accurate functional representation of human
disease in mouse models is known for only a very small sub-
set of these implicated genes. Here we discuss the findings in
genetic mouse models of schizophrenia that meet these criteria.
Intriguingly, studies among these mouse models have revealed
that, while long-term synaptic plasticity is relatively intact, a strik-
ing preponderance of short-term plasticity alterations suggesting
that the neural circuit dysfunction caused by these genetic risk
variants may likely be due in large part to alterations in presy-
naptic function that fundamentally impact synaptic computation
(Table 2).
THE 22q11.2 MICRODELETION AND RELATED GENES
Microdeletions of the 22q11.2 locus are among the most common
chromosomal abnormalities, occur predominantly de novo, and
account for 1–2% of sporadic schizophrenia cases (Karayiorgou
et al., 1995, 2010; McDonald-McGinn et al., 2001; Xu et al.,
2008). Individuals with the 22q11.2 microdeletion are character-
ized by a high incidence of emotional problems and a spectrum
of cognitive deficits, and approximately 30% eventually develop
schizophrenia or schizoaffective disorder in adolescence or early
adulthood (Pulver et al., 1994; Bearden et al., 2001; Woodin et al.,
2001; Sobin et al., 2005; Chow et al., 2006).
A mouse model has been created to recapitulate the human
deletion syndrome by creating an analogous deletion in the
mouse genome that spans a segment syntenic to the 1.5-Mb
human 22q11.2 microdeletion that results in the heterozygous
deletion of 27 genes (Stark et al., 2008). Behavioral analysis of
this mouse indicated both cognitive deficits, as manifested by
impaired spatial working memory and contextual and cued fear
learning, as well as deficits in sensorimotor gating—paralleling
findings in schizophrenia—as demonstrated by reductions in pre-
pulse inhibition (PPI) of acoustic startle (Swerdlow and Geyer,
1998; Stark et al., 2008). To further refine the interpretation of
behavioral assays, results from novel object recognition and latent
inhibition behavioral assays—that require hippocampal function
but are largely independent of PFC function—indicated that
purely hippocampal-dependent behaviors were intact suggesting
that the primary functional deficit in these animals was largely
restricted to dysfunction within the PFC (Fénelon et al., 2013).
Electrophysiological assessment of the 22q11.2-DS equivalent
mouse showed that while nearly all forms of short-term and
long-term plasticity tested in the hippocampus were unaltered
(with the exception of modest reductions in 100Hz induced
LTP at CA3-CA1 synapses), synapses onto layer V neurons in
the mPFC—although showing normal basic synaptic transmis-
sion and paired-pulse ratios—demonstrated enhanced synaptic
depression during high-frequency stimulus trains and reduc-
tions in the initial phase of the synaptic potentiation (short-
term potentiation) induced by the high frequency stimulus train
for LTP induction (Drew et al., 2011b; Fénelon et al., 2013).
Finally, in vivo recordings from mice performing a spatial work-
ing memory task have shown that the functional, synchronous
coupling between the microcircuits in the hippocampus and the
PFC is significantly reduced during working memory perfor-
mance in deletion mice suggesting that the working memory
deficits observed in these mice might be related to this dis-
connectivity (Sigurdsson et al., 2010). Overall these findings
of cognitive deficits in the face of largely normal hippocampal
electrophysiological function suggest that the primary dysfunc-
tion in the deletion syndrome mouse is likely due to a primary
functional deficit in PFC microcircuit function and the connec-
tivity between the PFC and the hippocampus. In addition to
these findings in mice that employ the full 27 gene microdele-
tion, in order to more precisely dissect the underlying dysfunc-
tion, further evaluations have been performed in mice in which
only single genes from within this region have been deleted
individually.
DGCR8
DGCR8 is a gene within the 22q11.2 microdeletion whose gene
product is involved with processing micro-RNAs (mi-RNAs)
within the nucleus which are involved with repressing translation
of their target mRNAs (Tomari and Zamore, 2005; Karayiorgou
et al., 2010). While homozygous deletion of DGCR8 is lethal,
heterozygous deletion such as occurs in the 22q11.2 deletion
syndrome results in the reduction of numerous mi-RNAs lead-
ing to enhanced expression of their targets due to the loss of
mi-RNA repression (Stark et al., 2008; Xu et al., 2013). Mice
missing one copy of the DGCR8 gene (DGCR8± mice) demon-
strate reduced PPI of acoustic startle, impaired performance in
spatial working memory, but, in contrast to deletion-syndrome
mice, both normal contextual and cued fear learning (Stark
et al., 2008). Similar to electrophysiology findings in the dele-
tion syndrome mouse, measures of both short-term and long-
term plasticity were found to be normal at CA3-CA1 synapses
in the hippocampus of DGCR8(±) mice, while synapses onto
layer V neurons in the mPFC showed normal paired-pulse ratios
(suggesting normal initial Pr) but enhanced synaptic depression
during high-frequency stimulus trains and reductions in the ini-
tial phase of the synaptic potentiation induced by high frequency
trains of stimuli (Fénelon et al., 2011). Thus, heterozygous dele-
tion of DGCR8 alone seems to be able to account for most of
the electrophysiological deficits found in the deletion syndrome
mouse while the absence of fear-learning deficits suggests the
involvement of other genes within the 27-gene deletion in these
behaviors.
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PRODH
PRODH is a gene within the 22q11.2 microdeletion whose gene
product is involved with L-proline degradation within mitochon-
dria and its homozygous or heterozygous deletion results in a
gene-dose dependent elevation in L-proline in both the periph-
ery and within the CNS (Phang et al., 2001; Karayiorgou et al.,
2010). Human subjects with hypomorphic mutations in their
PRODH gene have a disease called hyperprolinemia type I that
is characterized by seizures and significantly increased incidence
of schizophrenia and schizoaffective disorder (Phang et al., 2001;
Jacquet et al., 2005; Raux et al., 2007; Clelland et al., 2011).
Mice with homozygous functional deletion of the PRODH gene
(PRODH knockdown mice) demonstrate reduced PPI of acous-
tic startle, normal performance in spatial working memory tasks,
and reductions in both contextual and cued fear learning (Gogos
et al., 1999; Paterlini et al., 2005). Electrophysiological assess-
ment of CA3-CA1 hippocampal synapses with field recordings
in PRODH-deficient mice showed increased evoked EPSPs and
reduced paired-pulse ratios (depressing compared to facilitating
in control animals at a 20ms interval) both of which suggest
increased initial probability in NT release (Pr) in PRODH-
deficient mice (Paterlini et al., 2005). These mice also showed
decreased CA3-CA1 LTP induction which was notable for a
complete absence of its presynaptic component whereas control
animals showed increased Pr after LTP induction (Zakharenko
et al., 2003; Paterlini et al., 2005). Taken together these elec-
trophysiological results suggest that PRODH deficiency leads to
altered presynaptic function with increased initial Pr and an
inability of LTP induction to lead to further increases in initial
Pr. Interestingly, PRODH-deficient also mice showed evidence
of dopaminergic dysregulation within the PFC as evidenced by
enhanced hyperlocomotion and dopamine release within the
PFC upon amphetamine challenge as well as a possibly compen-
satory enhanced expression of the dopamine degradative enzyme
COMT (a gene located within the 22q11.2 microdeletion that
would be expected to be compromised in its ability to undergo an
equal compensatory upregulation in patients with the microdele-
tion). Overall, the findings in PRODH-deficient mice suggest pri-
marily alterations in presynaptic function that—despite normal
working memory performance in these mice—would be expected
lead to significant alterations in synaptic filtering and network
computation within the hippocampus (Tsodyks and Markram,
1997; Abbott and Regehr, 2004). Furthermore, although the
underlying mechanism remains to be resolved, PRODH hypo-
function also appears to lead to dopaminergic dysregulation and
studies in schizophrenics that have revealed a synergy between
PRODH and COMT hypofunction support this as a potentially
important disease mechanism (Raux et al., 2007).
DISC1
Disrupted in schizophrenia 1 (DISC1) is a gene that was impli-
cated in schizophrenia through its discovery as the gene disrupted
by a chromosomal translocation that cosegregated with mental
illness in a family pedigree prominently affected by schizophre-
nia, bipolar disorder, and major depression (St Clair et al., 1990;
Millar et al., 2000; Blackwood et al., 2001). The precise cellular
and biological role of the DISC1 gene product remains uncertain
and resolution of this question has been hindered by the fact that
its protein sequence appears to share no homology with other
known proteins (Millar et al., 2000). To determine possible func-
tions of Disc1, studies have identified numerous protein-binding
partners of Disc1 the most promising of which suggest that
Disc1 may play a significant role in modulating cellular function
through alterations in cAMP levels and protein kinase function.
Disc1 binds to and regulates the phosphodiesterase, PDE4b, and
mice with a DISC1 mutation that models the consequences of the
human chromosomal translocation demonstrate enhanced cAMP
levels due to decrease PDE4 activity (Millar et al., 2005; Kvajo
et al., 2011). Furthermore, Disc1 has also been shown to bind
to and inhibit the function of the protein kinase GSK3β (Mao
et al., 2009) leading to reduced phosphorylation of some of its
protein targets. Although in early development Disc1 shows a
broader expression pattern, in the adult brain prominent expres-
sion is restricted to the dentate gyrus and, to a lesser extent,
the CA1 regions within the hippocampal microcircuitry (Austin
et al., 2004). Based upon this expression pattern and given the
potential role of adult neurogenesis in schizophrenia and other
neuropsychiatric diseases, a number of studies have suggested a
potentially important role for DISC1 in regulating microcircuit
architecture through its regulation of neurogenesis in the dentate
gyrus (Ghashghaei et al., 2006; Reif et al., 2006, 2007; Mao et al.,
2009; Ming and Song, 2009; Inta et al., 2011; Kim et al., 2012).
Within neurons, Disc1 has been shown to be present in multi-
ple subcellular compartments including dendrites and dendritic
spines as well as in growth cones and axonal terminals suggest-
ing the possibility that Disc1 could regulate either postsynaptic or
presynaptic function (Millar et al., 2005; Kirkpatrick et al., 2006;
Taya et al., 2007; Bradshaw et al., 2008; Brandon and Sawa, 2011;
Randall et al., 2014).
Using a genetic mouse model employing a DISC1 muta-
tion that accurately recapitulates the consequences of the human
chromosomal translocation, a comprehensive battery of behav-
ioral analyses has revealed a pattern of cognitive deficits in
these mice that appears to reflect cognitive deficits found in
schizophrenia (Koike et al., 2006; Kvajo et al., 2008). Amongst
this battery of cognitive behavioral assays, Disc1 mutant mice dis-
played an isolated deficit in spatial working memory as indicated
by impaired performance on a delayed alternation t-maze task.
Significantly, largely hippocampus-dependent behavioral tasks—
contextual fear conditioning, novel object recognition, Morris
water maze, and the eight-arm radial maze win-shift paradigm—
all failed to reveal significant alterations in Disc1 mutant mice
(Kvajo et al., 2008). Taken together, the results of these behavioral
assays suggest an isolated deficit in the short-term maintenance
and utilization of information—as opposed to information stor-
age and retrieval—that likely results from information processing
dysfunction in the PFC rather than in the hippocampus (Compte
et al., 2000; Baddeley, 2012; Roux et al., 2012).
Electrophysiological assessment of granule cell mossy fiber
synapses onto CA3 neurons—motivated by the high expression
of Disc1 in the dentate gyrus—showed both normal basic synap-
tic transmission as well as normal LTP in response to 100Hz
stimulation (Austin et al., 2004; Kvajo et al., 2011). Measures of
short-term plasticity at these synapses, however, revealed reduced
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paired-pulse ratios (suggesting increased Pr) and reductions in
the short-term frequency facilitation characteristic of this synapse
both pointing to selective deficits in short-term plasticity in Disc1
mutant mice (Nicoll and Schmitz, 2005). Electrophysiological
assessment of CA3-CA1 hippocampal synapses, in contrast,
showed both normal long-term and short-term plasticity with the
exception of an isolated reduction in the initial, short-term synap-
tic potentiation induced by the 100Hz stimulus train employed
for LTP induction (Kvajo et al., 2008). Interestingly, this iso-
lated deficit in short-term synaptic potentiation at CA3-CA1
synapses may potentially represent a significant pathophysiology
for schizophrenia as a similar deficit in this short-term potenti-
ation mechanism was observed at mPFC synapses in both the
22q11.2-DS equivalent mice and DGCR8 (+/−) mice (Fénelon
et al., 2011, 2013). While assessment of the function of Disc1 at
synapses within the PFC has not been reported in Disc1 mutant
mice, a recent study employed in utero electroporation and opto-
genetic techniques to selectively examine the presynaptic role
of Disc1 at synapses onto cortical layer II/III pyramidal neu-
rons (Maher and LoTurco, 2012). This study provided evidence
that Disc1 may positively regulate neurotransmitter release as
Disc1 knockdown led to increased paired pulse ratios (consis-
tent with reduced Pr) as well as disrupted kinetics of evoked
synaptic responses potentially consistent with less synchronized
NT release. Taken together, the results of these synaptic func-
tion studies suggest a limited role of Disc1 in long-term synaptic
plasticity but a potentially significant role in regulating presy-
naptic short-term plasticity mechanisms that would be expected
to significantly impact both synaptic and network computation
(Abbott and Regehr, 2004).
CALCINEURIN
Calcineurin dysfunction has been implicated in the pathophys-
iology of schizophrenia (Gerber et al., 2003; Horiuchi et al.,
2007; Liu et al., 2007) with reduced expression or function as
the most likely responsible disease mechanism (Eastwood et al.,
2005). Calcineurin is a cytosolic Ca2+-dependent protein phos-
phatase that regulates many cellular processes throughout the
body including the CNS where is has been shown to regulate vari-
ous neuronal processes including synaptic plasticity (Groth et al.,
2003). Calcineurin-deficient mice display a number of behavioral
abnormalities relevant to schizophrenia including severe reduc-
tions in working memory performance and deficits in the PPI
of acoustic startle (Zeng et al., 2001; Miyakawa et al., 2003).
Furthermore, these studies in mice with a forebrain specific cal-
cineurin deficiency have described altered synaptic plasticity and
neural network performance suggesting that hypofunction of
calcineurin in schizophrenia could likewise alter synaptic plas-
ticity and lead to disruptions of normal information processing
(Cottrell et al., 2013; Suh et al., 2013).
It was originally reported that forebrain calcineurin deficiency
led most notably to severe working memory deficits as well as
to deficits in LTD at Schaffer collateral (CA3)—CA1 hippocam-
pal synapses (Zeng et al., 2001). This study further showed that
the frequency dependence of the stimulus required to induce
long-term plasticity was shifted in calcineurin-deficient mice such
that LTP (vs. LTD) induction was favored at lower than normal
stimulus frequencies suggesting that deficiencies in LTD were
permissive of LTP induction. Significantly, the LTD deficiency
appeared to be due to an alteration of a post-synaptic mecha-
nism since, in the genetic model employed, calcineurin was not
deficient in the CA3 presynaptic neurons as these synapses. In fur-
ther support of a post-synaptic mechanism, presynaptic function
and short-term plasticity were unaltered as evidenced by normal
PPR and post-tetanic potentiation (PTP). Although this study
failed to identify the precise functional defect that led to LTD
deficiency, the normal AMPA-R and NMDA-R mediated synap-
tic responses observed in calcineurin-deficient mice suggested
possible dysfunction in downstream postsynaptic LTD induction
mechanisms.
A follow-up study by this same group has recently described
apparent network dysfunction in the hippocampus of freely
behaving calcineurin-deficient mice (Suh et al., 2013). While
in vivo recording from dorsal CA1 showed normal place fields
and place cell activation during exploratory behavior, during rest
periods place cells were overactive and temporally disorganized
in their activity during sharp-wave ripple events (SWRs). The
authors suggest that, as SWRs during rest are believed to orches-
trate sequential “replay” of place cell activity in order to maintain
spatial information, the absence of sequential replay of place cells
during SWRs observed in calcineurin-deficient mice may under-
lie the severe spatial WM deficit previously described (Zeng et al.,
2001). Finally, in an effort to link synaptic plasticity alterations to
network dysfunction, the authors speculate that the LTD deficit
present in CA1 might be responsible for the enhanced excitabil-
ity within this neural circuitry that appeared to underlie the lack
of organized “replay” of place cells during SWRs in calcineurin-
deficient mice. Taken together the results of these two studies
suggest calcineurin deficiency in schizophrenia would most likely
have little impact upon short-term plasticity and synaptic filter-
ing but would disrupt the ability to sculpt information processing
by neural circuits by limiting the ability of LTD to down-regulate
synaptic gain post-synaptically in order to appropriately control
network excitability.
In contrast to the possible role of calcineurin in modulat-
ing postsynaptic plasticity in the hippocampus, another recent
study in calcineurin-deficient mice has reported deficits in presy-
naptic function within the PFC (Cottrell et al., 2013). Although
the cortical layer and synapse under study was not precisely
clarified, these synapses in the PFC showed normal PPR and
normal synaptic depression during 20Hz stimulation; however,
during 40Hz stimulus trains calcineurin-deficient mice showed
enhanced synaptic depression. Additional experiments in cul-
tured neurons employing synapto-pHluorins revealed impaired
synaptic vesicle exocytosis-endocytosis cycling suggesting that the
enhanced synaptic depression was due to augmented synaptic
fatigue that limited sustained NT release. Parallel experiments
at hippocampal mossy fiber–CA3 synapses—where calcineurin
remained expressed postsynaptically—showed similar deficits in
sustained NT release indicating that presynaptic deficiency of
calcineurin was responsible for the observed deficit. Further stud-
ies indicated that calcineurin-deficient mice also demonstrated
neural circuit dysfunction as evidenced by reduced power of γ-
oscillations in both PFC slices and in in vivo PFC recordings from
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mice exploring a novel environment. As γ-oscillations in the PFC
are believed to be critical for working memory and other execu-
tive functions and as these high-frequency oscillations rely heavily
upon sustained, high-frequency NT release, the observed deficits
in network function suggest the possibility that the MW impair-
ments in calcineurin-deficient mice may ultimately result from
presynaptic NT release dysfunction. Thus, the combined results
of this study provide a possible mechanism sequentially linking
presynaptic NT release dysfunction, to neural circuit dysfunction,
to cognitive and WM dysfunction that may be highly relevant to
understanding how dysfunction in short-term synaptic plasticity
could fundamentally underlie schizophrenia pathophysiology.
Taken together, the results from studies in calcineurin-
deficient mice indicate prominent deficits in WM and synaptic
plasticity while basic synaptic properties appear largely intact.
While this series of studies suggests calcineurin may play differ-
ent roles in regulating synaptic plasticity in different brain regions
(postsynaptic responses in the hippocampus vs. presynaptic neu-
rotransmitter release in the PFC), their findings consistently
point toward network-dysfunction in the context of alterations
in synaptic plasticity. Although none of these studies provides
an unequivocal causal link between synaptic plasticity deficits
and the observed network dysfunction, these results nonetheless
compellingly suggest that calcineurin deficiency or hypofunction
in schizophrenia may lead to similar synaptic plasticity alter-
ations that would lead to significant changes in the information
processing performed by neural circuits.
NRG1
Dysfunction in NRG1 signaling pathways has been implicated
in the pathophysiology of a variety of neuropsychiatric diseases
including schizophrenia (Stefansson et al., 2002; Bertram et al.,
2007; Thomson et al., 2007; O’Donovan et al., 2008; Goes et al.,
2009; Walker et al., 2010). The manifold NRG1 gene products
are EGF-like ligands that signal through ERBB receptor tyro-
sine kinases—most relevantly through ERBB4—to regulate a
large number of cellular processes including neuronal migra-
tion, synapse formation, myelination, synaptic transmission, and
synaptic plasticity and both their normal signaling and altered
signaling in neuropsychiatric diseases have been comprehensively
reviewed recently (Mei and Nave, 2014). Although NRG1 has
been implicated in an equivocal manner as a schizophrenia risk
gene—primarily by human candidate gene studies—only a very
small percentage of identified risk variants affect protein coding
regions raising significant questions as to whether most identi-
fied non-coding variants lead to enhanced or decreased NRG1
signaling (Chen et al., 2006;Walss-Bass et al., 2006; Mei and Nave,
2014). As there is evidence supporting either enhanced or reduced
NRG1 signaling in schizophrenia, no clear picture has emerged
as to whether human NRG1 disease involves hypofunction or
hyperfunction and this has led to the creation of distinct mouse
models with opposing types of alterations in NRG1-ERBB signal-
ing (Hashimoto et al., 2004; Petryshen et al., 2005; Hahn et al.,
2006; Bertram et al., 2007; Parlapani et al., 2010; Shibuya et al.,
2010). Despite the lack of a resolution of this very important issue
that critically underlies the generation of valid genetic mouse
models of disease, studies in both models of altered NRG1-ERBB
signaling nonetheless reveal potential roles and sites of action for
these molecules to alter synaptic plasticity and network function
in schizophrenia.
Mouse models of both enhanced and reduced NRG1-ERBB
signally display a variety of schizophrenia related behaviors. Mice
with functional knockdown of NRG1 signaling show locomotor
hyperactivity, impaired PPI of startle, impaired working memory,
and abnormal social behaviors (Boucher et al., 2007; Chen et al.,
2008; Ehrlichman et al., 2009; Shamir et al., 2012). Intriguingly,
mice overexpressing components of NRG1-ERBB signaling dis-
play a similar pattern of behavioral alterations (Deakin et al.,
2009, 2012; Yin et al., 2013; Luo et al., 2014). Importantly, at
least some of these behaviors appear to result from semi-acute
actions of NRG1-ERBB signaling—rather than complex devel-
opmental effects that could significantly impact neural circuit
architecture—as perturbing or restoring expression acutely in
adulthood can cause or partially reverse behavioral alterations,
respectively (Yin et al., 2013; Agarwal et al., 2014; Luo et al., 2014).
That many behavioral alterations appear due to acute actions of
NRG1 suggests that underlying neural circuit dysfunction may be
due to alterations in synaptic transmission and plasticity.
Until recently, the majority of studies exploring the impact of
NRG1 signaling have focused upon the function of glutamatergic
synapses where ERBB receptors co-localize with PSD95 suggest-
ing a likely role in the regulation AMPA and NMDA receptors
(Garcia et al., 2000; Huang et al., 2000; Hahn et al., 2006). Despite
this fact, both pharmacological and genetic manipulation of
NRG1 signaling does not appear to significantly affect basal glu-
tamatergic synaptic transmission (Huang et al., 2000; Kwon et al.,
2005; Bjarnadottir et al., 2007; Iyengar and Mott, 2008; Pitcher
et al., 2008). Similarly—and in notable contrast to the findings
from most other mouse models based upon schizophrenia risk
genes—the preponderance of manipulations of NRG1 signaling
have not revealed alterations in short-term glutamatergic synaptic
plasticity suggesting NRG1 signaling may preferentially act post-
synaptically at these synapses (Huang et al., 2000; Kwon et al.,
2005; Iyengar and Mott, 2008; Pitcher et al., 2008; Chen et al.,
2010; but see Bjarnadottir et al., 2007; Woo et al., 2007; Deakin
et al., 2012). Conversely, NRG1 signaling has a significant effect
upon both induction and expression of LTP with manipulations
enhancing signaling suppressing LTP while reduced signaling
facilitates LTP by removing an apparent tonic suppression (Huang
et al., 2000; Kwon et al., 2005; Bjarnadottir et al., 2007; Pitcher
et al., 2008; Chen et al., 2010; Agarwal et al., 2014, but see Deakin
et al., 2012; Jiang et al., 2013). Although alterations in LTP at these
synapses are usually interpreted as due to perturbations of gluta-
matergic synaptic physiology, complicating this interpretation of
NRG1-ERBB signaling is accumulating evidence that NRG1 reg-
ulation of hippocampal LTP may be due to more powerful NRG1
facilitating actions at hippocampal GABA-ergic synapse (Chen
et al., 2010; Shamir et al., 2012).
NRG1 signaling may particularly impact GABA-ergic trans-
mission as its principal receptor, ErbB4, is selectively expressed in
interneurons, particularly within the parvalbumin positive (PV)
interneurons known to be fundamental to regulating synchro-
nized network activity (Huang et al., 2000; Bartos et al., 2007;
Fisahn et al., 2009; Vullhorst et al., 2009; Fazzari et al., 2010).
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Enhanced NRG1 signaling increases the amplitude of GABA-ergic
synaptic events, most likely through a presynaptic mechanism
that increases initial Pr to facilitate GABA release that further
leads to altered short-term synaptic plasticity as manifested by
enhanced short-term depression (Woo et al., 2007; Chen et al.,
2010; Li et al., 2011). A potentially critical importance of the reg-
ulation of synaptic function and excitability specifically in PV
interneurons by NRG1 is suggested by the alterations in net-
work activity, behavior, and glutamatergic LTP that have been
observed both in response to broad alterations in NRG1 signal-
ing as well as when these manipulations are selectively confined
to PV interneurons (Woo et al., 2007; Fisahn et al., 2009; Chen
et al., 2010; Li et al., 2011; Andersson et al., 2012; Deakin et al.,
2012; Shamir et al., 2012; Del Pino et al., 2013).
Overall, the findings from mouse models with a variety of
manipulations of NRG1 signaling show prominent deficits in
WM, synchronized neural circuit dysfunction likely due to PV
interneuron dysfunction, and alterations in both long-term and
short-term synaptic plasticity in the context of largely normal
basal synaptic function. Furthermore, while on face the preva-
lence of LT vs. ST synaptic plasticity alterations observed seems
at odds with results from mouse models based upon other
schizophrenia risk genes, recent findings suggest that these LT
plasticity alterations may in fact arise indirectly from altered
presynaptic Pr in GABA-ergic neurons that display altered ST
plasticity. Yet interpreting the causal impact of NRG1 signaling
upon neural circuit function will require much further clarifica-
tion because, in addition to its more acute effects upon synaptic
transmission and synaptic plasticity, its developmental roles in
neuronal migration, synapse formation, and myelination further
suggests that altered NRG1 signaling in schizophrenia and other
disease states may also lead to significant changes in neural circuit
architecture.
RGS4
Reduced expression of the “regulator of g-protein signaling”
protein RGS4 has been implicated in schizophrenia. Normally,
RGS4 acts a negative regulator of GPCR signaling due to its
GAP-activity (GTPase-activating protein) that serves to terminate
cycles a G-protein signaling by converting active Gα subunits to
their inactive state (De Vries et al., 2000). A number of stud-
ies have indicated that RGS4 deficiency leads to enhanced GPCR
signaling and that this may ultimately lead to a decrease in the
probability of NT release from presynaptic terminals (decreased
presynaptic Pr). Such an alteration in presynaptic function would
be expected to lead changes in short-term synaptic plasticity that
would affect the computation of neural circuits suggesting that
such functional changes could contribute to the dysfunction in
schizophrenia.
The paper that best describes the possible synaptic mechanism
and impact of RGS4 deficiency upon presynaptic function, how-
ever, is a report that examines the effects of RGS2 deficiency—
rather than RGS4 deficiency—upon synaptic function in cul-
tured hippocampal neurons (Han et al., 2006). This study shows
that presynaptic RGS2 deficiency permits enhanced presynaptic
mGluR signaling that leads to increased inhibition of presy-
naptic voltage-gated Ca2+ channels (most likely through direct
Gβγ inhibition of N-type or P/Q-type channels). The reduced
activity of these presynaptic Ca2+ channels in RGS2-deficient
synapses results in reduced neurotransmitter release in response
to APs. When RGS2 is present in presynaptic terminals these
hippocampal synapses are either depressing or non-facilitating
by paired-pulse paradigms, indicative of a high presynaptic Pr.
RGS2-deficient synapses, however, show paired-pulse facilitation
suggesting that in the absence of RGS2 the presynaptic Pr is
decreased. In additional support of this action at voltage-gated
Ca2+ channels, RGS2-deficient synapses required more extracel-
lular Ca2+ for the same degree of NT release as WT synapses yet
both synapses showed indistinguishable NT release in response
to hypertonic sucrose challenges. The results of this study indi-
cate that RGS2 deficiency leads to changes in presynaptic function
that result in changes in short-term synaptic plasticity and further
suggests that a similar scenario may likely result in cases of RGS4
deficiency.
Although whether a similar mechanism of alteration in synap-
tic function occurs in cases of RGS4 deficiency has not been
reported, two studies support this possibility by showing that
RGS4 has a functional relationship with voltage-gated Ca2+ chan-
nel activity analogous to that of RGS2. Rather than exploring
effects upon synaptic transmission, however, these two studies
that look at RGS4 regulation of voltage-gated Ca2+ channels
examine the resulting impact upon action potentials (Saugstad
et al., 1998; Ding et al., 2006). One study found that condi-
tions that enhanced expression of RGS4 inmedium spiny neurons
(MSNs) of the striatum led to the removal of muscarinic GPCR
inhibition of voltage-gated Ca2+ channel activity. The enhanced
voltage-gated Ca2+ channel activity that resulted from increases
in RGS4 expression permitted enhanced Ca2+ currents during
APs that recruited activation of Ca2+-activated K+-channels that
served to regularize AP rhythms in these striatal neurons. The
results of this paper indicate that RGS4 normally serves to reduce
voltage-gated Ca2+ channel inhibition and suggest that RGS4
deficiency would lead to reduced voltage-gated Ca2+ activity.
A second study found that the normal suppression of Ca2+-
activated K+ currents by mGluR activation in CA1 hippocampal
pyramidal neurons could be nearly abolished by inclusion of
RGS4 in the recording pipette (Saugstad et al., 1998). Although
this study did not directly show that the RGS4 enhancement of
Ca2+-activated K+ currents was due to removal of mGluR medi-
ated inhibition of voltage-gated Ca2+ channels, this would seem
to be the likely mechanism. Taken together, the results of these
two studies supporting RGS4-mediated enhancement of voltage-
gated Ca2+ channel activity, although they did not examine
synaptic physiology, support the possibility that RGS4 deficiency
could lead to a reduced voltage-gated Ca2+ channel activity in
presynaptic terminals that would result in reduced NT release and
altered short-term synaptic plasticity.
A final study directly explored the impact of RGS4 deficiency
upon synaptic plasticity at MSNs in the striatum by employ-
ing RGS4-deficient mice (Lerner and Kreitzer, 2012). This study
examined an endocannabinoid (eCB) mediated LTD (eCB-LTD)
at MSN synapses that is dependent upon mGluR-Gq mediated
generation of eCB in the post-synaptic neuron that travels to
the presynaptic neuron to inhibit presynaptic NT release by
Frontiers in Synaptic Neuroscience www.frontiersin.org November 2014 | Volume 6 | Article 28 | 12
Crabtree and Gogos Synaptic plasticity and neuropsychiatric disease
lowering Pr. Normally this LTD pathway can be modulated by
the activation of additional postsynaptic GPCRs, but in RGS4-
deficient mice this modulation is absent. Through a series of
elegant experiments this study showed that this GPCR modula-
tion of LTD occurs through alterations in cAMP/PKAmodulation
of RGS4 activity that alters the ability of RGS4 to suppress
mGluR-dependent production of the eCB retrograde messenger
responsible for the LTD. Thus, although by a much more com-
plicated mechanism than described for RGS2, RGS4 deficiency
similarly results in alterations in presynaptic NT release proba-
bility (Pr). Further, although this study did not directly address
changes in ST synaptic plasticity, the inability to modulate presy-
naptic Pr due to RGS4 deficiency would be predicted to lead
to a decreased ability to modulate ST plasticity at this synapse
as well.
Taken together, the results of these four studies suggest that
the action of RGS4 should normally serve to increase presy-
naptic NT release probability and that RGS4 deficiency would
lead to reductions in Pr causing reduced NT release. While
only LT plasticity consequences have been directly explored in
RGS4-deficient mice, the results of these studies supporting that
presynaptic Pr is a likely target for RGS4modulation strongly sug-
gest that ST synaptic plasticity—and consequently neural circuit
computation—would be strongly impacted by RGS4 deficiency in
schizophrenia.
DYSBINDIN
Reductions in dysbindin expression and function have been
implicated in schizophrenia and results from a number of stud-
ies point toward a role for dysbindin in regulating presynaptic
short-term plasticity by modulation of the probability of neuro-
transmitter release from synaptic terminals. Although a detailed
understanding of dysbindin function remains to be determined,
its expression in central synaptic terminals in the mammalian
CNS and its association with synaptic vesicles suggests a possible
role in the regulation of NT release (Benson et al., 2001; Talbot
et al., 2006).
Perhaps the most informative study of dysbindin function
was performed at the glutamatergic neuromuscular junction
(NMJ) in Drosophila (Dickman and Davis, 2009), a system
whose amenability to genetic manipulation permits rapid clarifi-
cation of the detailed molecular mechanisms of gene action. This
study demonstrated that presynaptic dysbindin deficiency led to
reduced Ca2+-sensitivity of NT release, enhanced paired-pulse
facilitation of post-synaptic responses, enhanced facilitation of
post-synaptic responses during trains of stimuli, and a failure of
homeostatic upregulation of the number of NT vesicles released
per stimulus (quantal content) upon postsynaptic receptor block-
ade. Each of these results is consistent with a role of dysbindin
in enhancing the Pr of presynaptic NT release (and dysbindin
deficiency leading to reduced NT release), most likely through
an action of dysbindin that enhances the Ca2+ sensitivity of the
NT release machinery. This study convincingly illustrated that
dysbindin deficiency altered ST plasticity by transforming a mod-
estly facilitating synapse into a strongly facilitating synapse. This
finding supports the possibility that dysbindin-deficient synapses
in the mammalian CNS would have similar alterations in ST
plasticity that would be expected to significantly alter synaptic
and neural circuit computation.
A recent study of synaptic transmission onto layer V pyramidal
neurons in the mPFC in dysbindin-null mice reported a num-
ber of findings consistent with the altered presynaptic function
described at the Drosophila NMJ (Saggu et al., 2013). Reduced
amplitudes of evoked EPSCs, reduced frequency of mEPSCs, a
reduced RRP of synaptic vesicles, reduced SV cycling upon depo-
larization (as determined by FM1-43 studies), and decreased
Ca2+ flux into synaptosomes upon depolarization all consistently
point toward a decrease in the presynaptic Pr of NT release in
dysbindin-deficient synapses mice. Furthermore, although not
reaching statistical significance, this study performed assays to
determine Pr more directly and showed a ∼35% reduction in
presynaptic Pr in dysbindin-deficient mice. Thus, although this
study did not directly examine either short-term or long-term
plasticity by traditional electrophysiological assays, taken together
these findings strongly support a reduced presynaptic Pr due to
dysbindin deficiency that would be expected to lead to alterations
in short-term plasticity in neural circuits in the mammalian
mPFC.
Despite the strong support for dysbindin deficiency leading
to decreased presynaptic function through reduced Pr (Dickman
and Davis, 2009; Saggu et al., 2013), a recent study in the hip-
pocampus of dysbindin-deficient mice did not see alterations in
ST plasticity (Tang et al., 2009). This study of Schaffer collateral
input to CA1 in the hippocampus reported a nearly doubledmag-
nitude of LTP at these synapses in dysbindin-deficient mice but
both normal paired-pulse facilitation and normal LTD. Yet, taken
together, these studies of synaptic function in dysbindin-deficient
animals suggest that the most likely role of dysbindin is in regulat-
ing presynaptic NT release and that dysbindin deficiency leads to
decreases in NT release by reducing presynaptic Pr. Furthermore,
as presynaptic Pr is the prime determinant controlling short-
term plasticity at synapses, dysbindin deficiency in schizophrenia
would be predicted to most significantly alter short-term plastic-
ity and lead to alterations in neural circuit computation that could
underlie disease symptomology.
AKT1
Reductions in AKT1 expression and function have been impli-
cated in schizophrenia in a number of recent studies (Emamian
et al., 2004; Zhao et al., 2006; Balu et al., 2012). AKT is a pro-
tein kinase that has many cytosolic protein targets in a variety
signaling pathways both in the CNS as well as in non-neuronal
tissues (Yang et al., 2004). AKT1-deficient mice show alterations
in the dendritic architecture of mPFC pyramidal neurons as well
as working memory deficits that are believed to be represen-
tative of analogous deficits found in schizophrenia (Lai et al.,
2006). Although the role AKT1 in neuronal and synaptic func-
tion remains under-explored, two studies in animal models with
reduced AKT1 expression have revealed alterations in synaptic
plasticity (Guo and Zhong, 2006; Balu et al., 2012).
While neither of these two studies provides a clear mechanis-
tic explanation of the plasticity alterations observed in AKT1-
deficient animals, the study of the glutamatergic synapse at the
NMJ of Drosophila provides a more comprehensive analysis (Guo
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and Zhong, 2006). In this study the authors describe a novel long-
term depression (LTD) evoked by high frequency stimulation that
quantal analysis revealed to be presynaptic in origin as the quan-
tal size remained unchanged but the quantal content (reflecting
the number of released neurotransmitter vesicles per stimulated
event) was reduced. Although basic NMJ responses were normal
in AKT mutant flies, this novel LTD was significantly reduced
in mutant flies with low expression of AKT while normal LTD
could be rescued by acute over-expression of WT AKT. Despite
the evidence of a presynaptic locus for this LTD, in AKT mutant
flies with deficient LTD, measures of baseline presynaptic func-
tion such as short-term depression, short-term facilitation, and
PTP were found to be normal. Given that these results support
that the observed LTD in WT flies was due to reduced presy-
naptic Pr and that all forms of baseline presynaptic function in
AKT-deficient flies were normal—including inferred presynap-
tic Pr—suggests a role of AKT in the induction of changes in
presynaptic Pr during LTD protocols that is reduced or absent in
AKT-deficient flies. Interestingly, such a mechanistic deficiency is
somewhat similar to the deficient control of presynaptic Pr upon
eCB-LTD induction in the striatum of RGS4-deficient mice where
RGS deficiency impacts the ability to modulate presynaptic Pr
(Lerner and Kreitzer, 2012). Regardless of the details of the mech-
anism underlying deficient LTD at the NMJ in AKT-deficient flies,
an inability to appropriately reduce presynaptic Pr by long-term
plasticity mechanisms would consequently lead to an inability to
alter presynaptic short-term plasticity normally at AKT-deficient
synapses.
In a separate study in AKT1-deficient mice deficits in long-
term plasticity were observed at multiple synapses in the hip-
pocampus (Balu et al., 2012). AKT1-deficient mice showed
deficits in LTP in CA1 upon Schaffer collateral stimulation (SC-
CA1) and deficits in LTP in the dentate gyrus upon medial
perforant path stimulation (EC-GC). At both of these sites short-
term plasticity of synaptic responses during the tetanus were
normal in AKT1-deficient mice suggesting no major alteration
in baseline presynaptic short-term plasticity mechanisms. The
post-tetanic short-term potentiation, however, although normal
at SC-CA1 synapses, was completely absent at EC-GC synapses
suggesting a more severe plasticity deficit at the synapses onto
granule cells in the dentate gyrus. Despite the profound deficits
in synaptic plasticity described in AKT1-deficient mice in this
report, given that the mechanisms underlying these deficits were
not further experimentally pursued it is difficult to speculate
upon the precise role of AKT1 function at these synapses.
Taken together the results of these two studies in AKT-deficient
animals indicate that AKT1 may play an significant role in reg-
ulating long-term synaptic plasticity and that AKT1 deficiency
in schizophrenia may result in similar long-term plasticity alter-
ations that could contribute to disease symptomology.
AUTISM
With the exception of schizophrenia, perhaps the most rele-
vant studies evaluating synaptic plasticity that employ genetic
mouse-models based upon strong candidate risk genes in human
neuropsychiatric disease have been carried out in models of
autism. Autism spectrum disorder (ASD) is a heterogeneous
neurodevelopmental with an approximate 1% prevalence in the
population that has a heritability supporting a strong genetic
component (Abrahams and Geschwind, 2008). ASD is symp-
tomology is characterized by abnormal reciprocal social inter-
actions, impaired communication (particularly involving lan-
guage but also non-verbal), and repetitive behaviors (American
Psychiatric Association, 2013). Among the diverse array of autism
risk genes that have been identified both from syndromes with
autistic features as well as though genome analyses of large patient
populations are a significant number of genes known to affect
synaptic function and plasticity (Zoghbi, 2003; Abrahams and
Geschwind, 2008; Südhof, 2008; Silverman et al., 2010; Gauthier
and Rouleau, 2012; Iossifov et al., 2012; Neale et al., 2012; O’Roak
et al., 2012; Sanders et al., 2012). And, in contrast genetic mouse
models of schizophrenia which predominantly display selec-
tive alterations in short-term synaptic plasticity, mouse models
based on ASD risk genes have shown a more balanced combina-
tion of both short- and long-term synaptic plasticity alterations
(Arguello and Gogos, 2012).
Functional imaging studies in autism overall support that
long-range connections between brain regions (such as from
higher-order association areas to the frontal lobe) show reduced
functional connectivity while local microcircuitry and short-
range connections show evidence of enhanced connectivity
(Mundy, 2003; Belmonte et al., 2004; Geschwind and Levitt,
2007; Markram and Markram, 2010; Ecker and Murphy, 2014).
Assessment of network activity in autism with EEG and MEG
has shown reduction of local microcircuit activity evidenced
by reduced gamma oscillations at rest and during sensory pro-
cessing and facial presentation tasks (Wilson et al., 2007; Sun
et al., 2012; but see Orekhova et al., 2007). Furthermore, long-
range connectivity between brain regions appears impaired as,
despite increased strength of theta rhythms locally, coherence
of these rhythms between brain regions was reduced (Murias
et al., 2007). That some of these network alterations have also
been seen in unaffected relatives of autistics suggests that both
local and long-range network dysfunction may represent signif-
icant intermediate endophenotypes (Rojas et al., 2011). Finally,
in vivo studies of long-term plasticity have indicated that at
least a subset of autistics show enhanced LTP- and LTD-like
phenomena that are consistent with theories of hyper-plasticity
in autism (Markram and Markram, 2010; Oberman et al.,
2010).
Although a number of mouse models of autism based on
human genetic findings have been made, neuronal and synaptic
function have been most thoroughly explored in mice mod-
eled upon Rett syndrome (MECP2 gene deletion) and fragile X
syndrome (FMR1 gene deletion). While both of these human dis-
orders are syndromic in nature and manifest a variety of clinical
features in addition to ASD symptomology, important insights
about synaptic plasticity alterations underlying autism sympto-
mology can still be gleaned from these mouse models despite
these potentially complicating factors. Both Fmr1 andMecp2 null
mice demonstrate deficits in long-term memory and learning
that are consistent with the possibility of an underlying deficit in
long-term synaptic plasticity (Moretti et al., 2006; MacLeod et al.,
2010). While there are no reports on working memory (MW)—a
short-term memory process thought to rely largely upon short-
term synaptic plasticity—in Mecp2 null mice, MW memory may
Frontiers in Synaptic Neuroscience www.frontiersin.org November 2014 | Volume 6 | Article 28 | 14
Crabtree and Gogos Synaptic plasticity and neuropsychiatric disease
be deficient in Fmr1 null mice although reports are conflicting
(Van Dam et al., 2000; Yan et al., 2004; Mongillo et al., 2008;
Udagawa et al., 2013).
Both Mecp2 and Fmr1 null mice show alterations in presy-
naptic short-term plasticity. Decreased paired-pulse facilitation
observed in Mecp2 null mice suggests increased initial Pr for
neurotransmitter release that shifts synaptic function in the
direction of short-term depression (Moretti et al., 2006; Weng
et al., 2011). These mice have also shown reduced PTP, a
more sustained form of short-term plasticity induced by high-
frequency activity (Weng et al., 2011). In Fmr1 null mice,
although paired-pulse facilitation is normal, these mice showed
strongly increased augmentation—a longer-lasting component of
short-term plasticity—and reduced short-term depression that is
entirely due to presynaptic mechanisms and were at least par-
tially attributable to enhanced presynaptic Ca2+ influx due to AP
broadening and increases in the readily releasable pool of NT vesi-
cles during high frequency activity (Deng et al., 2011, 2013; Wang
et al., 2014). These changes also resulted in changes in synaptic
information processing as there was a significant enhancement of
responses during natural stimulus trains that were most notable
during high-frequency epochs of activity (Deng et al., 2011).
BothMecp2 and Fmr1 null mice show alterations in long-term
plasticity. MeCP2 null mice have been shown to have impaired
hippocampal LTP and LTD in the hippocampus and impaired
LTP inmotor and sensory cortex (Asaka et al., 2006; Moretti et al.,
2006; Weng et al., 2011). Although Fmr1 null mice display nor-
mal hippocampal LTP they have impaired neocortical LTP and
show enhanced LTD in both the hippocampus and cerebellum
(Godfraind et al., 1996; Paradee et al., 1999; Huber et al., 2002;
Li et al., 2002; Koekkoek et al., 2005; Larson et al., 2005; Hayashi
et al., 2007).
The limited studies of network activation in mouse models of
autism suggest enhanced activity in local microcircuitry. Drug-
induced gamma oscillations are enhanced in Mecp2 null mice
and, although gamma oscillations have not been assessed in Fmr1
null mice, these mice also display local network dysfunction in
the form of enhanced up-states during slow wave oscillations
(Hays et al., 2011; McLeod et al., 2013). These enhancements
in local network activity in mouse models of autism are consis-
tent with some reports of enhanced high-frequency oscillations
observed in humans studies (Orekhova et al., 2007). Coupled
with the findings in human studies, these complementary find-
ings inmousemodels of autism suggest that significant alterations
in both long-term and short-term synaptic plasticity may likely
be responsible for the information processing and behavioral
dysfunction present in the human disease.
A STRATEGY TO DISSECTING NEURAL CIRCUIT
DYSFUNCTION IN GENETIC MOUSE MODELS OF
NEUROPSYCHIATRIC DISEASE
While a small number of etiologically valid genetic mouse mod-
els of schizophrenia and autism have begun to enable exploration
of the underlying dysfunction in neural circuits and synaptic
plasticity in these diseases, similar progress for most other neu-
ropsychiatric diseases has been limited to date as equally robust
predisposing genetic variants necessary to recapitulate disease in
animal models have yet to be identified for these diseases. Yet
it is both the complex nature of the genetic risk of neuropsy-
chiatric disease as well as our current symptoms-based vantage
point that continue to present a number of challenging issues that
more broadly complicate and confound the strategic approach to
unraveling root causes underlying neural circuit dysfunction in
genetic mouse models of neuropsychiatric diseases.
ISSUE—GENETIC ARCHITECTURE
Genomic studies of neuropsychiatric disease have identified a
surprisingly large and diverse array of risk genes. Despite this
genetic heterogeneity, the fact that identified risk genes are prefer-
entially involved in synaptic function, growth, and maintenance
as well as axonal guidance suggests that genetic risk factors for
neuropsychiatric disease may converge upon the common sub-
strate of neural circuit function (Walsh et al., 2008; Glessner
et al., 2009; Guilmatre et al., 2009; Akil et al., 2010; Insel et al.,
2010; Gilman et al., 2011; O’Dushlaine et al., 2011; Sanders et al.,
2011). In addition, despite heterogeneity, a small number of rare
but highly penetrant genetic risk variants have been identified
that reliably lead to disease that is clinically indistinguishable
from the majority of disease cases (Farooqi and O’Rahilly, 2005;
Peltonen et al., 2006). Although these highly penetrant genetic
variants are usually only responsible for a very small percentage
of cases of the broader disease, their high reliability to cause dis-
ease renders them invaluable, essential tools in creating mouse
models that faithfully recapitulate disease. While a small number
of such high-risk genetic variants have been identified in cases
of schizophrenia, autism, and AD that have enabled the creation
of reliable disease models in mice, for many common neuropsy-
chiatric diseases—e.g., major depression, bipolar disorder, anxi-
ety disorders, attention-deficit hyperactivity disorder—similarly
high-risk genetic variants that reliably lead to human disease have
yet to be identified thus leaving valid genetic mouse models of
these diseases currently out of reach (Pulver et al., 1994; Hardy,
1997; Murphy et al., 1999; Millar et al., 2000; Blackwood et al.,
2001; Hatton et al., 2006; Clifford et al., 2007; Ramocki et al.,
2009; Vassos et al., 2010; Neul, 2012). While the genetic selective
pressures—such as the strong selection pressures against retain-
ing risk genes for socially debilitating and early-onset diseases
like autism and schizophrenia that largely preclude successful
reproductive transmission—that shape the genetic architecture of
disease may be substantially different for diseases such as major
depression, it nonetheless seems reasonable to posit (and hope)
that high-risk genetic variants for these diseases in fact exist yet
have eluded detection and remain to be found. Based upon these
considerations, creating reliable genetic mouse models of disease
must begin with the identification of highly penetrant genetic
variants and in the case of neuropsychiatric diseases in which such
genetic variants remain to be identified our understanding of the
details of neural circuit dysfunction in these diseases likely must
patiently await this first crucial step.
ISSUE—OVERLAPPING DISEASE PHENOMENOLOGY
Further complicating the understanding of the causality between
genes and disease, genomic studies have revealed a surpris-
ing overlapping genetic risk among multiple neuropsychiatric
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diseases that raises significant questions as to the validity of the
boundaries between these diseases (Craddock and Owen, 2005;
Craddock et al., 2006; Friedman et al., 2008; Guilmatre et al.,
2009; McCarthy et al., 2009; O’Donovan et al., 2009; Williams
et al., 2010; Smoller et al., 2013). That is, in many cases the same
genes implicated in increased risk for one neuropsychiatric dis-
ease have been shown to predispose to increased risk for multiple
other distinct neuropsychiatric diseases. Furthermore, although
some genetic variants appear to lead to narrower, better-defined
clinical phenotypes, genomic studies have also revealed that in
some cases the same genetic variant can be found in patients
with different clinical diagnoses (St Clair et al., 1990; Hatton
et al., 2006; Bijlsma et al., 2009; McCarthy et al., 2009; Ramocki
et al., 2009; Shi et al., 2009; Wang et al., 2009; Karayiorgou et al.,
2010; Shinawi et al., 2010). The potential significance of these
results is further supported by heritability studies that have shown
that within family pedigrees the presence of one neuropsychi-
atric illness is frequently associated with cross-vulnerability to
other neuropsychiatric illnesses (Biederman et al., 1991; Maier
et al., 1993; Lichtenstein et al., 2009b, 2010; Rommelse et al.,
2010; Sullivan et al., 2012). Furthermore, beyond considering
these concerns of genetic promiscuity among distinct neuropsy-
chiatric diseases further suggests that beyond choosing highly
penetrant genetic variants, the clearest path to understanding dis-
tinct diseases through genetic mouse models may further require
carefully choosing among genetic variants for those associated
with narrow, well-defined clinical presentations.
Beyond these concerns, however, the additional overlapping
symptomology and overlapping responsiveness to medication
found between some diseases raises the legitimate possibility
that the boundaries between “distinct” diseases may be inher-
ently blurred due to a true shared causation (Milberger et al.,
1995; Citrome et al., 2005; Lake and Hurwitz, 2007; O’Donovan
et al., 2009; Sinzig et al., 2009; Ivleva et al., 2010; Gros et al.,
2012; Zbozinek et al., 2012). For example, while NMDA receptor
hypofunction has been implicate in the causation of schizophre-
nia, recent studies in rodent models support NMDA receptor
hypofuction in autism suggesting the possibility of a contin-
uum of related dysfunction between and among distinct diseases
(Mohn et al., 1999; Gandal et al., 2012; Saunders et al., 2012;
Schmeisser et al., 2012; Won et al., 2012). Taken together, these
multiple issues of overlapping disease phenomenology suggest
the possibility that the traditional diagnostic criteria used to cre-
ate distinct boundaries between diseases based upon behavioral
manifestations—while clinically useful in disease management—
may not be ideally suited as a scientific framework from which
to determine underlying disease mechanisms which may instead
require the development of more refined and quantifiable mea-
sures targeted at directly assessing endpoints related to brain
function including the function of neural circuits (Geyer, 2006;
Gould and Gottesman, 2006; Benes, 2007; Psychiatric GWAS
Consortium Coordinating Committee, 2009; Luck et al., 2011;
Smoller et al., 2013).
ISSUE—ALTERNATIVE MEASURES OF FUNCTION
Unlike traditional physiological diseases such as cardiovas-
cular disease, diabetes, or obesity, the understanding of
neuropsychiatric disease processes is currently hampered by the
underdevelopment and underutilization of analytic measures that
provide simple yet precise quantitative readouts of the function
and status of the underlying physiological systems that directly
contribute to disease pathogenesis (Gould and Gottesman, 2006).
For example, psychiatric diagnosis and evaluation as put forth
by the DSM-V is based upon a checklist of behavioral signs
and symptoms that are considered either present or absent in
a binary manner and are far removed from any direct quan-
titative measure of underlying brain or neural circuit function
(American Psychiatric Association, 2013). Furthermore, most
current evaluative measures in neuropsychiatric disease are inher-
ently complex—e.g., evaluation of complex phenomena such as
social function, judgment, and language—and do not obviously
point to precisely circumscribed loci of neural circuit dysfunction.
Due to this complexity, these measures—while both interesting
and clinically relevant in terms of monitoring the progression
and the functional impact of disease—are not terribly useful as
scientific bases for a reductionist approach aimed at revealing fun-
damental diseasemechanisms (Insel et al., 2010).Moreover, many
of these complex manifestations seem to be uniquely human
in nature do not appear to present obvious translatable equiv-
alents that could readily permit correlative evaluation in mouse
models. These considerations highlight the intense need in neu-
ropsychiatric diseases for the development of more simplified and
precise parameter assays that directly and quantitatively report
upon underlying pathophysiological processes such as neural cir-
cuit dysfunction (Gould and Gottesman, 2006; Akil et al., 2010;
Insel et al., 2010).
Analysis of disease related endophenotypes may represent the
most effective strategy to provide the simplified and precisely
quantitative functional measures required to efficiently dissect
fundamental disease mechanisms. Endophenotypes are relatively
simple, quantifiable, and heritable characteristics present in both
individuals diagnosed with disease and in unaffected members
within their familial pedigrees and are therefore believed to rep-
resent disease vulnerability traits (Gould and Gottesman, 2006).
Compared to “top level” symptoms in neuropsychiatric disease
that often appear to be uniquely human in nature without clear
parallels in mouse models, the more rudimentary nature of
endophenotypes present the further advantage that their assays
are frequently readily translatable into mouse models (Geyer,
2008; Ecker and Murphy, 2014). In consensus recognition of the
need for more quantifiable measures in neuropsychiatric disease,
an initial, though partial, effort to address these issues strate-
gically has recently begun to be laid out by the NIMH in the
form of their proposed Research Domain Criteria (RDoC) project
initiative.
While assessment of endophenotypes frequently provides little
direct clinical utility, their quantification is scientifically valu-
able as endophenotypes are believed to represent the most
fundamental consequences of the basic pathological processes
underlying the more complex manifestations neuropsychiatric
diseases. From the standpoint of assessing suspected neural cir-
cuit dysfunction in neuropsychiatric disease, particularly appeal-
ing among endophenotypes are the neurophysiological measures
which quantify rather stereotyped responses to very simplified
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stimuli (Turetsky et al., 2007; Luck et al., 2011). These assays,
through assessing the dysfunction of simplified neural circuits
involved with very rudimentary information processing, present
an effective and strategic platform from which to reveal the cellu-
lar and molecular details of the neuronal and synaptic alterations
underlying neural circuit dysfunction in neuropsychiatric dis-
ease. To better appreciate the refined analytical power and broad
utility such assays present for guiding a detailed mechanistic
understanding of neural circuit dysfunction in neuropsychiatric
disease, it is useful to specifically examine the strategic approach
to understanding neural circuit dysfunction in mouse models of
schizophrenia.
OPTIMIZING THE APPROACH TO NEURAL CIRCUIT ANALYSIS:
SCHIZOPHRENIA AS EXAMPLE
Currently the most prevalent approach to understanding neu-
ral circuit dysfunction in genetic mouse models of schizophrenia
has involved assessing working memory deficits in these animals
coupled with electrophysiological recordings from the underly-
ing brain regions believed to contribute most to working memory
performance. While not as striking as the positive symptomology
of schizophrenia, the pervasive cognitive deficits in schizophre-
nia have presented a tractable experimental endophenotype for
examining disease-relevant alterations in behavior and neural
circuit function in genetic mouse models (Glahn et al., 2003;
Heinrichs, 2005; Saperstein et al., 2006; Forbes et al., 2009;
Arguello and Gogos, 2010, 2012). As such, assessment of working
memory in genetic mousemodels of schizophrenia has been com-
monly employed and any working memory deficits detected have
been interpreted as reflecting dysfunction of neural circuits in
either the hippocampus or the medial prefrontal cortex (Arguello
and Gogos, 2010, 2012). Motivated by such findings these brain
regions have then been subsequently probed more directly with
electrophysiological assays in attempts to detect and localize neu-
ronal dysfunction within specific neurons or synapses and to
determine the precise mechanisms underlying this dysfunction
and this approach has successfully revealed—consistent withWM
deficits—prominent alterations in short-term synaptic plasticity
(Zeng et al., 2001; Kvajo et al., 2008, 2011; Mongillo et al., 2008;
Jentsch et al., 2009; Sigurdsson et al., 2010; Cottrell et al., 2013;
Fénelon et al., 2013).
Despite the strong validity, disease-relevance, and transla-
tional potential of working memory tasks as a framework from
which to assess and reverse neuronal and synaptic dysfunction
in mouse models, the inherent complexity of such tasks limits
their potential to identify and precisely localize underlying neu-
ronal dysfunction (Arguello and Gogos, 2010, 2012). Specifically,
during a spatial working memory task information processing in
disparate brain regions involving sensory, motor, motivational,
volitional, appetitive, and fear and anxiety related neural cir-
cuits is likely influencing behavioral performance in addition to
the neural circuit activation within the mPFC and hippocam-
pus (Gisquet-Verrier and Delatour, 2006; McNab and Klingberg,
2008; Edin et al., 2009; Baddeley, 2012).
As the ultimate goal of investigations in genetic mouse models
of neuropsychiatric disease is to reveal the precise mechanisms of
neuronal and synaptic dysfunction underlying the neural circuit
dysfunction in these diseases, the optimal assays of in vivo neural
circuit function should ideally be as simple and uncomplicated
as possible such that any dysfunction observed can be confi-
dently and unambiguously attributed to a distinct neural circuit
or brain region that can then be directly targeted with invasive,
high-resolution electrophysiological assays. Although finding a
functional measure that can be purely attributed to a single,
well-defined neural circuitry is a non-trivial hurdle, a num-
ber of schizophrenia-related neurophysiological endophenotypes
involving sensory evoked responses may come the closest to fit-
ting this requirement (Turetsky et al., 2007; Thaker, 2008). While
the study of the neural circuits underlying these endophenotypes
has yet to be aggressively pursued, due to their exquisite simplicity
these endophenotypes may represent the most tractable and effi-
cient analytical path toward understanding the discrete neuronal
and synaptic mechanisms underlying neural circuit dysfunction
in well-defined and valid genetic animal models of schizophre-
nia (Goff et al., 1980; Javitt et al., 1994; Freedman et al., 1996;
Swerdlow et al., 2001; Grunwald et al., 2003; Kumari et al., 2003;
Schall et al., 2003; Luck et al., 2011).
Specifically, among the many neurophysiological assays show-
ing characteristic alterations in schizophrenics, the sensory
evoked response endophenotypes involving PPI of acoustic star-
tle, P50 auditory evoked potential suppression (P50), and acoustic
mismatch negativity (MMN) appear to reflect information pro-
cessing abnormalities within relatively simple and isolated neural
circuits (Clements et al., 1998; Bramon et al., 2004; Light and
Braff, 2005; Swerdlow et al., 2006; Brockhaus-Dumke et al.,
2008). From a reductionist point of view, the most compelling
characteristic of these three endophenotype assays is that they
involve neural circuit processing that is either entirely or largely
preattentive—and thus nearly reflexive—in nature (Naatanen,
1992). These measures thus appear to represent read-outs of rudi-
mentary neural circuit computation with minimal contaminating
influences from other neural circuitry that might otherwise con-
found interpretation of results (Naatanen, 2003; Braff and Light,
2004). As such, these assays of neural circuit function that are
largely devoid of the complications of attentional, motivational,
or cognitive control may be optimal assays of neural circuit
function in mouse models of schizophrenia—through use of
analogous assays in rodents that have been developed for each of
these measures—as they examine hard-wired, relatively inflexible
computational elements that present a greatly simplified system
in which to explore the discrete neuronal and synaptic mech-
anisms underlying neural circuit dysfunction (Swerdlow et al.,
2001; Gould and Gottesman, 2006; Metzger et al., 2007; Geyer,
2008; Javitt et al., 2008; Ehrlichman et al., 2009; Luck et al., 2011).
Furthermore, as these neurophysiological assays employ either
pairs or trains of acoustic stimuli delivered at very brief intervals,
these assays bear a striking resemblance to electrophysiologi-
cal assays that employ similarly brief intervals of stimulation to
determine short-term plasticity properties of synapses suggesting
the possibility that abnormalities observed in neurophysiological
assays may reflect underlying alterations in short-term synaptic
plasticity (Freedman et al., 1996; Garrido et al., 2009; Blundell
et al., 2010). In summary, while no neural circuit exists in iso-
lation from the influence of other circuits within the brain, the
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neurophysiological assays of preattentive schizophrenia endophe-
notypes that activate rudimentary neural circuits come close to
this ideal and may represent the optimal assays to guide the
elucidation of the synaptic and neuronal mechanisms underly-
ing neural circuit dysfunction in valid genetic mouse models of
schizophrenia.
CONCLUDING REMARKS
The progress in unraveling the mechanisms underlying neu-
ral circuit dysfunction in human neuropsychiatric diseases has
been enormously accelerated by the recent advances in human
genomics that have enabled the identification of an abundance of
candidate genetic risk variants that may be the responsible agents
for causing disease symptomology. Specifically, the identification
of highly penetrant risk genes for schizophrenia and autism has
led the creation of etiologically valid mouse models for these
diseases that have enabled detailed investigations directed at iden-
tifying synaptic, neuronal, and neural circuit dysfunction. Studies
in these mouse models have revealed both neural circuit dysfunc-
tion as well as a variety of synaptic plasticity alterations that may
be responsible for this dysfunction given the critical role of synap-
tic plasticity in sculpting information flow within neural circuits.
Overall, while mouse models of schizophrenia have shown a pre-
ponderance of short-term plasticity alterations consistent with
disease symptomology, mousemodels of autism appear to present
a more balanced combination of both short-term and long-term
plasticity alterations that may be consistent with the more pro-
found dysfunction present in the clinical picture of this spectrum
of disorders.
These initial successes with schizophrenia and autism strongly
suggests that, despite the failure to date to identify highly pen-
etrant genetic risk variants for many of the more common
neuropsychiatric diseases such as anxiety disorders and major
depression, this strategic approach may represent the necessary
pathway forward for these diseases as well. Yet, beyond negoti-
ating the complexities of the genetic architecture of neuropsy-
chiatric diseases, in order to effectively identify neural circuit
dysfunction and resolve the underlying neuronal and synaptic
mechanisms that lead to it, additional considerations need to be
thoughtfully addressed. As a symptomology-based approach to
neuropsychiatric disease has revealed significant overlapping dis-
ease phenomenology, dissecting the causes of unique forms of
neural circuit dysfunction underlying disease will likely require
further identification and utilization of more simplified, quan-
tifiable endophenotypes that examine precisely defined param-
eters more directly and more closely related to alterations in
specific brain regions and functions. In addition to the advan-
tage that assays of such endophenotypes are readily translatable
to assess neural circuit dysfunction in mouse models of dis-
ease, assessing the genetic risk variants contributing to individual
endophenotypes—compared to the global risk for disease based
upon symptomology—should facilitate dissecting disease mech-
anisms due to the likely identification of a much smaller and
more manageable number of genes responsible for dysfunction.
Finally, although our current understanding of even themost fun-
damental aspects of normal neural circuit function remain rudi-
mentary, the continuing technical advances in in vivo imaging,
electrophysiology, and optogenetics are beginning to help reveal
new levels of details of normal neural circuit that will enable
more sophisticated assessment of neural circuit function in dis-
ease. Taking these considerations together, the strategic approach
to understanding neural circuit dysfunction in neuropsychiatric
disease is rapidly evolving on multiple technical fronts and now
seems poised to shortly make major revelations regarding the
mechanisms of neural circuit dysfunction in these diseases.
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